Ribavarin and Dizziness aggravated - a phase IV clinical study of FDA data

Summary:

Dizziness aggravated is reported as a side effect among people who take Ribavarin (ribavirin), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Mirtazapine, and have Insomnia.

The phase IV clinical study analyzes which people have Dizziness aggravated when taking Ribavarin. It is created by eHealthMe based on reports of 426 people who have side effects when taking Ribavarin from the FDA, and is updated regularly.

What is Ribavarin?

Ribavarin has active ingredients of ribavirin. It is often used in hepatitis c. eHealthMe is studying from 439 Ribavarin users. Check the latest studies of Ribavarin.

What is Dizziness aggravated?

Dizziness aggravated is found to be associated with 2,762 drugs and 971 conditions by eHealthMe. Check the latest studies of Dizziness aggravated.

On Jul, 18, 2026

426 people reported to have side effects when taking Ribavarin.
Among them, 25 people (5.87%) have Dizziness aggravated.

Could Ribavarin cause Dizziness aggravated?

Among these 25 people:

How long have people been on Ribavarin when they have Dizziness aggravated? *

What is the gender of people who have Dizziness aggravated when taking Ribavarin? *

female: 40 %
male: 60 %

What is the age of people who have Dizziness aggravated when taking Ribavarin? *

What are other drugs people take besides Ribavarin? *

Lorazepam: 8 people, 32.00%
Mirtazapine: 8 people, 32.00%
Ribavirin: 5 people, 20.00%
Pegasys: 5 people, 20.00%
Sovaldi: 2 people, 8.00%
Clonazepam: 2 people, 8.00%
Copegus: 2 people, 8.00%
Sulfamethoxazole And Trimethoprim: 2 people, 8.00%
Amitiza: 1 person, 4.00%
Atenolol: 1 person, 4.00%

What are other side effects people have besides Dizziness aggravated? *

Fainting (loss of consciousness and postural tone): 8 people, 32.00%
Back Injury: 8 people, 32.00%
Joint Swelling: 8 people, 32.00%
Ear Disorder: 8 people, 32.00%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 8 people, 32.00%
White Blood Cell Count Decreased: 7 people, 28.00%
Rashes (redness): 7 people, 28.00%
Weakness: 5 people, 20.00%
Fatigue (feeling of tiredness): 5 people, 20.00%
Dry Skin: 5 people, 20.00%

What are the existing conditions these people have? *

Insomnia (sleeplessness): 4 people, 16.00%
Constipation: 2 people, 8.00%
Uterine Leiomyoma (uterine benign tumour derived from smooth muscle): 1 person, 4.00%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 4.00%
Indigestion: 1 person, 4.00%
High Blood Cholesterol: 1 person, 4.00%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 4.00%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 4.00%
Dysmenorrhea (painful menstruation): 1 person, 4.00%
Blood Disorder: 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ribavarin and have Dizziness aggravated?

- Check whether Dizziness aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ribavarin:

Ribavarin (439 reports)

Browse all side effects of Ribavarin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dizziness aggravated:

Dizziness aggravated (2,762 drugs)

Browse all the conditions that are associated with Dizziness aggravated:

Dizziness aggravated (971 conditions)

Related publications that referenced our studies

Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on ribavirin (the active ingredients of Ribavarin) and Ribavarin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.